Eiken Chemical Co Ltd - Product Pipeline Analysis, 2019 Update - ResearchAndMarkets.com

The "Eiken Chemical Co Ltd (4549) - Product Pipeline Analysis, 2019 Update" company profile has been added to ResearchAndMarkets.com's offering.

Summary

Eiken Chemical Co Ltd (Eiken Chemical), a subsidiary of Hitachi High-Technologies Corp is a medical equipment provider that offers molecular genetic products and medical devices. The company manufactures and markets clinical diagnostics and equipment, among others. It also provides fecal immunochemical test, molecular genetics, and microbiology, among others. Eiken Chemical's fecal immunochemical test products provide OC-sensor series that are fully automated immunochemical fecal test for detecting gastrointestinal bleeding. The company offers IVD and PCOT devices, immunological reagents, and serological reagents, among others. It markets its products through its distributors located across Japan and abroad. Eiken Chemical is headquartered in Tokyo, Japan.

Scope:

• The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
• The report analyzes all pipeline products in development for the company Eiken Chemical Co Ltd
• The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
• The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
• The report provides detailed description of products in development, technical specification and functions
• The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

• Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
• Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
• To formulate effective Research & Development strategies
• Develop market-entry and market expansion strategies
• Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
• Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
• Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Key Topics Covered:

• Eiken Chemical Co Ltd Company Overview
• Eiken Chemical Co Ltd Company Snapshot
• Eiken Chemical Co Ltd Pipeline Products and Ongoing Clinical Trials Overview
• Eiken Chemical Co Ltd - Pipeline Analysis Overview
• Eiken Chemical Co Ltd - Key Facts
• Eiken Chemical Co Ltd - Major Products and Services
• Eiken Chemical Co Ltd Pipeline Products by Development Stage
• Eiken Chemical Co Ltd Pipeline Products Overview
• HAT LAMP
• HAT LAMP Product Overview
• LAMP Test - Chagas Disease
• LAMP Test - Chagas Disease Product Overview
• Multi Item Testing Chip
• Multi Item Testing Chip Product Overview
• Next Generation Fully Automated Genetic Testing Device
• Next Generation Fully Automated Genetic Testing Device Product Overview
• OTC Reagent - Fecal Immunochemical Test
• OTC Reagent - Fecal Immunochemical Test Product Overview
• Ov16/Wb123 Biplex Rapid Test
• Ov16/Wb123 Biplex Rapid Test Product Overview
• Eiken Chemical Co Ltd - Key Competitors
• Eiken Chemical Co Ltd - Key Employees
• Eiken Chemical Co Ltd - Locations And Subsidiaries
• Head Office
• Other Locations & Subsidiaries
• Recent Developments
• Eiken Chemical Co Ltd, Recent Developments
• Apr 25, 2019: Eiken Chemical announced its financial results for the fiscal year ended March 31, 2019
• Apr 25, 2019: Regarding the establishment of the new EIKEN ROAD MAP 2019 management framework and the new medium-term management plan
• Apr 23, 2019: First molecular diagnostic test launched for the detection of malaria caused by Plasmodium vivax parasites
• Aug 23, 2016: WHO Recommends Loopamp PURE MTBC for Diagnosis of Pulmonary TB
• Jan 27, 2015: Development of the next-generation compact fully automated genetic testing device and multi-item testing chip, using the LAMP method.
• Oct 23, 2014: Eiken Chemical Reports Net Sales Of JPY15.8 Billion In H1 Fiscal 2015
• Sep 02, 2014: Nagasaki University Develops New Ebola Test
• May 17, 2013: Eiken Chemical's LAMP Malaria Test Kit Likely To Boost Malaria Elimination Efforts
• Appendix
• Methodology
• About the Author
• Contact Us
• Disclaimer

Companies Mentioned

• Cosmo Bio Co Ltd
• Seikagaku Corp
• Nissui Pharmaceutical Co Ltd
• Sysmex Corp
• Medical & Biological Laboratories Co Ltd

For more information about this company profile visit https://www.researchandmarkets.com/r/2p5n6s

View source version on businesswire.com: https://www.businesswire.com/news/home/20200124005231/en/